Literature DB >> 19624074

Medical and endovascular management of critical limb ischemia.

Alan B Lumsden1, Mark G Davies, Eric K Peden.   

Abstract

Critical limb ischemia (CLI) is the term used to designate the condition in which peripheral artery disease has resulted in resting leg or foot pain or in a breakdown of the skin of the leg or foot, causing ulcers or tissue loss. If not revascularized, CLI patients are at risk for limb loss and for potentially fatal complications from the progression of gangrene and the development of sepsis. The management of CLI requires a multidisciplinary team of experts in different areas of vascular disease, from atherosclerotic risk factor management to imaging, from intervention to wound care and physical therapy. In the past decade, the most significant change in the treatment of CLI has been the increasing tendency to shift from bypass surgery to less invasive endovascular procedures as first-choice revascularization techniques, with bypass surgery then reserved as backup if appropriate. The goals of intervention for CLI include the restoration of pulsatile, inline flow to the foot to assist wound healing, the relief of rest pain, the avoidance of major amputation, preservation of mobility, and improvement of patient function and quality of life. The evaluating physician should be fully aware of all revascularization options in order to select the most appropriate intervention or combination of interventions, while taking into consideration the goals of therapy, risk-benefit ratios, patient comorbidities, and life expectancy. We discuss the incidence, risk factors, and prognosis of CLI and the clinical presentation, diagnosis, available imaging modalities, and medical management (including pain and ulcer care, pharmaceutical options, and molecular therapies targeting angiogenesis). The endovascular approaches that we review include percutaneous transluminal angioplasty (with or without adjunctive stenting); subintimal angioplasty; primary femoropopliteal and infrapopliteal deployment of bare nitinol, covered, drug-eluting, or bioabsorbable stents; cryoplasty; excimer laser-assisted angioplasty; excisional atherectomy; and cutting balloon angioplasty.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19624074     DOI: 10.1583/08-2657.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  10 in total

1.  Comparison of cryoplasty and conventional angioplasty for treating stenotic-occlusive lesions of the femoropopliteal arteries in diabetic patients: immediate, mid-term and long-term results.

Authors:  R Fossaceca; G Guzzardi; M Di Terlizzi; I Divenuto; E Malatesta; P Cerini; C Cusaro; A Carriero
Journal:  Radiol Med       Date:  2012-02-10       Impact factor: 3.469

2.  Management of critical limb ischemia.

Authors:  Cornelius J Woelk
Journal:  Can Fam Physician       Date:  2012-09       Impact factor: 3.275

Review 3.  An overview of optimal endovascular strategy in treating the femoropopliteal artery: mechanical, biological, and procedural factors.

Authors:  Nicolas W Shammas
Journal:  Int J Angiol       Date:  2013-03

4.  Lipopolysaccharide and hypoxia significantly alters interleukin-8 and macrophage chemoattractant protein-1 production by human fibroblasts but not fibrosis related factors.

Authors:  T Eleftheriadis; V Liakopoulos; B Lawson; G Antoniadi; I Stefanidis; G Galaktidou
Journal:  Hippokratia       Date:  2011-07       Impact factor: 0.471

5.  Relationship between regional spending on vascular care and amputation rate.

Authors:  Philip P Goodney; Lori L Travis; Benjamin S Brooke; Randall R DeMartino; David C Goodman; Elliott S Fisher; John D Birkmeyer
Journal:  JAMA Surg       Date:  2014-01       Impact factor: 14.766

Review 6.  Clinical application of laser treatment for cardiovascular surgery.

Authors:  Masayoshi Okada; Masato Yoshida; Yoshihiko Tsuji; Hiroyuki Horii
Journal:  Laser Ther       Date:  2011

7.  High-sensitivity cardiac troponin and natriuretic peptide with risk of lower-extremity peripheral artery disease: the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Kunihiro Matsushita; Lucia Kwak; Chao Yang; Yuanjie Pang; Shoshana H Ballew; Yingying Sang; Ron C Hoogeveen; Bernard G Jaar; Elizabeth Selvin; Christie M Ballantyne; A Richey Sharrett; Aaron R Folsom; Gerardo Heiss; Josef Coresh; Alan T Hirsch
Journal:  Eur Heart J       Date:  2018-07-01       Impact factor: 35.855

Review 8.  The role of directional atherectomy in critical-limb ischemia.

Authors:  Prakash Krishnan; Arthur Tarricone; Simon Chen; Samin Sharma
Journal:  Ther Adv Cardiovasc Dis       Date:  2021 Jan-Dec

9.  Network analysis of unstructured EHR data for clinical research.

Authors:  Anna Bauer-Mehren; Paea Lependu; Srinivasan V Iyer; Rave Harpaz; Nicholas J Leeper; Nigam H Shah
Journal:  AMIA Jt Summits Transl Sci Proc       Date:  2013-03-18

10.  Prognostic Factors in Patients Treated with Drug-Coated Balloon Angioplasty for Symptomatic Peripheral Artery Disease.

Authors:  Fragiska Sigala; George Galyfos; Kyriakos Stavridis; Konstantinos Tigkiropoulos; Ioannis Lazaridis; Dimitrios Karamanos; Vangelis Mpontinis; Nikolaos Melas; Ioulia Zournatzi; Konstantinos Filis; Nikolaos Saratzis
Journal:  Vasc Specialist Int       Date:  2018-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.